SCHEMBL4424451

SCHEMBL4424451

CC(Nc1nc(Cl)nc(Nc2cn(C)cn2)n1)c1ccc(C#N)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 14/20 0.41
JAK3 P52333 12/20 0.39
JAK1 P23458 7/20 0.39
AURKA O14965 1/20 0.39
ABL1 P00519 1/20 0.39
NTRK1 P04629 1/20 0.39
RET P07949 1/20 0.39
FGR P09769 1/20 0.39
FGFR1 P11362 1/20 0.39
CSNK2A2 P19784 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39
FLT3 P36888 1/20 0.39
LIMK1 P53667 1/20 0.39
SIK1 P57059 1/20 0.39
PRKCZ Q05513 1/20 0.39
ALK Q9UM73 1/20 0.39
IDH1 O75874 1/20 0.38
ACVR1 Q04771 1/20 0.37
NFKB1 P19838 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2160830 1.00 JAK2 (0.41) JAK2JAK3JAK1AURKAABL1
SCHEMBL2161817 0.88 JAK2 (0.44) JAK2JAK3JAK1AURKAABL1
SCHEMBL2161052 0.86 JAK2 (0.50) JAK2JAK3JAK1AURKAABL1
SCHEMBL4425201 0.83 MAPT (0.41) JAK2IDH1
SCHEMBL2161754 0.83 MAPT (0.41) JAK2IDH1
SCHEMBL1396161 0.75 JAK2 (0.70) JAK2JAK3JAK1AURKAABL1
SCHEMBL2161006 0.75 JAK2 (0.70) JAK2JAK3JAK1AURKAABL1
SCHEMBL1396069 0.74 JAK2 (0.42) JAK2JAK3JAK1AURKAABL1
SCHEMBL2162078 0.73 LMNA (0.46)
SCHEMBL2160850 0.72 JAK2 (0.52) JAK2JAK3JAK1AURKAABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009150462-A1 TRICYCLIC 2,4-DIAMIN0-L,3,5-TRIAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF CANCER AND MYELOPROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2009-12-17 WO disclosed